J. Kroll

发表

Characterization of new estrogen receptor destabilizing compounds: effects on estrogen-sensitive and tamoxifen-resistant breast cancer.

Martin R. Schneider, N. Heinrich, J. Hoffmann, 2004, Journal of the National Cancer Institute.

Selective inhibition of sequence-specific protein-DNA interactions by incorporation of 6-thioguanine: cleavage by restriction endonucleases.

J. Maybaum, W. Roethel, J. Kroll, 1991, Molecular pharmacology.

Effects of incorporation of 6-thioguanine into SV40 DNA.

J. Maybaum, W. Roethel, J. Kroll, 1987, Molecular pharmacology.